Inventor · disambiguated record
Danny Frumkin
Also filed as: Frumkin Danny
10 granted patents·8 pending applications·24 citations·filing 2010–2025
84Inventor score
Top patents by PatentIndex Score
18 records- 0191US9476100B1Methods for diagnosing bladder cancerNUCLEIX LTD·Filed 2015·Granted Oct 25, 2016·14 cites·22 claims
- 0285US11434528B2Methods and systems for detecting methylation changes in DNA samplesNUCLEIX LTD·Filed 2020·Granted Sep 6, 2022·2 cites·18 claims
- 0379US9752187B2Categorization of DNA samplesWASSERSTROM ADAM·Filed 2012·Granted Sep 5, 2017·3 cites·17 claims
- 0477US12378602B2Methods and kits for determining the efficiency of plasma separation from whole bloodNUCLEIX LTD·Filed 2023·Granted Aug 5, 2025·0 cites·14 claims
- 0577US2025051839A1Methods and systems for detecting methylation changes in dna samplesNUCLEIX LTD·Filed 2024·Application pending·0 cites
- 0677US2025346949A1Methods and kits for determining the efficiency of plasma separation from whole bloodNUCLEIX LTD·Filed 2025·Application pending·0 cites
- 0776US9783850B2Identification of source of DNA samplesFrumkin Danny·Filed 2011·Granted Oct 10, 2017·3 cites·25 claims
- 0876US9458503B2Methods for distinguishing between natural and artificial DNA samplesWASSERSTROM ADAM·Filed 2010·Granted Oct 4, 2016·2 cites·5 claims
- 0976US2024287617A1Kits and methods for detecting cancer-related mutationsNUCLEIX LTD·Filed 2024·Application pending·0 cites
- 1074US2024209448A1Kits and methods for diagnosing lung cancerNUCLEIX LTD·Filed 2024·Application pending·0 cites
- 1173US12152273B2Methods and systems for detecting methylation changes in DNA samplesNUCLEIX LTD·Filed 2022·Granted Nov 26, 2024·0 cites·28 claims
- 1268US11629375B2Methods and kits for determining the efficiency of plasma separation from whole bloodNUCLEIX LTD·Filed 2019·Granted Apr 18, 2023·0 cites·14 claims
- 1364US11952632B2Kits and methods for detecting cancer-related mutationsNUCLEIX LTD·Filed 2019·Granted Apr 9, 2024·0 cites·20 claims
- 1462US11866786B2Kits and methods for diagnosing lung cancerNUCLEIX LTD·Filed 2019·Granted Jan 9, 2024·0 cites·9 claims
- 1562US2025092461A1Personalized cancer management and monitoring based on dna methylation changes in cell-free dnaNUCLEIX LTD·Filed 2023·Application pending·0 cites
- 1660US2025011858A1Whole genome cpg analysisNUCLEIX LTD·Filed 2022·Application pending·0 cites
- 1756US2024026453A1Detecting methylation changes in dna samples using restriction enzymes and high throughput sequencingNUCLEIX LTD·Filed 2021·Application pending·0 cites
- 1856US2024093302A1Non-invasive cancer detection based on dna methylation changesNUCLEIX LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Danny Frumkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →